Market Cap 5.41B
Revenue (ttm) 3.13B
Net Income (ttm) 359.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 11.48%
Debt to Equity Ratio 0.59
Volume 600
Avg Vol 900
Day's Range N/A - N/A
Shares Out 221.89M
Stochastic %K 10%
Beta 0.57
Analysts Strong Sell
Price Target N/A

Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Generics segment offers oral, respiratory, and other generic and specialty products for the retail market. The Branded segment offers branded generics and in-licensed pr...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 44 20 7399 2760
Address:
1 New Burlington Place, London, United Kingdom
Latest News on HKMPF
No data available.